Shewhart Charts for COVID-19 Reported Deaths

ISQua is very pleased to present the introduction to the use of Shewhart charts to understand variation in COVID mortality to our membership and wider community. We believe this is very important as  decisions are made on how to respond to the current and potentially future wavers of the pandemic.

As countries around the world face a second or third wave of the COVID-19 pandemic, there is renewed interest in public data on epidemic outcomes including reported deaths, cases, testing, hospitalization, and intubations.  As cases started climbing around the world, deaths in many areas remained constant, but it was only a matter of time before that was going to change.  As one report noted:

Something rather odd is happening in the two European nations worst hit by COVID-19. The UK and Italy have a rising number of cases but a stable and very low number of deaths, even weeks after the cases started rising again.

When would we know how soon deaths would start to pick up?  By what method could we know?

The number of reported deaths — as with anything we measure — will fluctuate. Without a method to understand if these changes simply reflect random variability, we will struggle to recognize if conditions are improving or deteriorating. Governments and institutions face decisions about opening and closing our societies that could be the difference between life and death.

How can we know which patterns of variation in reported data signal a meaningful change in epidemic conditions – and which patterns do not? At the cornerstone of the science of improvement is a theory of variation designed to monitor changing systems through a relatively simple chart method developed by Walter Shewhart almost a century ago.  The Shewhart chart method and theory has been applied successfully to some of the world’s most pressing problems in healthcare and society. In a global pandemic, Shewhart’s charts have been an invaluable tool in making sense of an increasingly complex data environment because they provide a theory for understanding variation in data that can serve as a basis for taking action. Such methods are needed to learn from reported COVID-19 data to support leaders and organizations making decisions and taking actions.

The Shewhart chart:

  • plots the reported data over time,
  • establishes a center line (average of all data points) and upper and lower limits within a given period,
  • fits the centerline and limits to the trajectory of the data.

There are statistical rules for Shewhart charts to signal special causes of variation in reported data patterns (i.e., not part of the daily fluctuations we expect to see). Two that have been applied to COVID-19 include:

1. any one data point above the upper limit or below the lower limit and

2. eight consecutive data points above or below the center line. 

Countries around the world are experiencing the epidemic differently, and many locations are finding that the frequency of disease and death has come in waves. To model the trajectory of COVID-19 reported daily deaths, we have created hybrid Shewhart control charts to model for a specific geographical region one or more particular epochs of the epidemic. We are modeling this trajectory with the four epochs shown in Figure 1.

Figure 1.  Four epochs associated with daily reported COVID-19 deaths 

figure 1

Below is an example of our hybrid Shewhart chart for the United Kingdom as of November 1, 2020 from the ISQua COVID-19 research page that makes charts available for all countries with daily updates.  At this time, the United Kingdom is experiencing their second Epoch 2 growth of this pandemic (Figure 2).

Figure 2. United Kingdom daily reported COVID-19 deaths (March 7 – November 1, 2020)

figure 2

The red dots signal the approximate day when a pattern in the data indicated a meaningful change.  Regarding rapid detection of these changes, we can select the date range on the toolbar and see on the image below (Figure 3) that the initial sign of increased COVID-19 deaths in the United Kingdom was on September 18 (first red data point) and then again on October 16 (last red data point).  Both red dots signaled eight or more consecutive days with reported deaths above the centerline – one of the two signals the chart is designed to detect.

Figure 3. United Kingdom daily reported COVID-19 deaths (September 1 – November 1, 2020)

figure 3

Ironically, on the same day that our chart detected the first meaningful increase in COVID-19 daily deaths in the United Kingdom, news outlets were reporting on why the number of deaths was so low and stable given the increase in COVID-19 cases, referencing weekly data reports from the Office of National Statistics.  Looking at COVID-19 deaths and cases daily and weekly is critical, but without a method to distinguish between normal fluctuations in the data and changes that are special, we risk flying blindly throughout the rest of the pandemic reacting to individual data points.  What would have happened if news reports and the Office of National Statistics did not report “low deaths” around the time of September 17, but rather identified it as an early signal of trouble – giving the country’s leadership and people more than a month’s head start on what was to come?  On October 31, a four-week lock down for England was announced – 44 days after the Shewhart chart detected a signal that the trajectory of daily reported deaths had changed for the worse in the UK as a whole.         

We see the same situation unfolding in many countries now, including Italy and the United States.  We cannot continue to give COVID-19 a head-start on our actions because we are responding to individual or weekly data points.  Whether we are measuring hospitalizations, cases or deaths, we must apply an empirically-based theory of variation to understand the trajectory of the virus that can guide our actions and the time-tested Shewhart Chart is our best method to do this.      

Recent Blog Articles

Stay in Touch

We bring you the latest research, expert opinions, and industry updates in healthcare safety and quality – so you’re always in the know.

Follow us on social media

Nourhan Kawtharani


Nourhan, a quality and safety coordinator with eight years of experience in ambulatory healthcare in Lebanon, aims to deepen her understanding of the systemic and holistic approach to healthcare through this fellowship.

She aims to identify gaps and develop tailored interventions that address specific contexts rather than applying general solutions. Engaging with diverse professionals and perspectives during this educational journey will expand the application of these concepts across different cultural settings.

Nourhan emphasizes the importance of promoting a culture of continuous learning and improvement within healthcare institutions, considering it a vital leadership responsibility to integrate quality and safety initiatives into the organizational culture.

Nourhan's commitment to patient safety and quality management includes sourcing practical resources and transforming insights into actionable knowledge to drive continued progress in healthcare practices and outcomes.

This will close in 0 seconds

Elom Otchi


Elom is passionate about improving quality of care and patient safety outcomes.

In view of this, he has had the opportunity to work in various capacities with various organisations including AfIHQSA, WHO, UNICEF and others undertaking research, supporting the development of national quality policies and strategies, facilitating the establishment of quality governance systems across all the levels of the health sector and building capacity of national and sub-national quality leads/teams to institutionalize the practice of quality and patient safety across the continent.

He has also worked extensively across all levels of care in the health sector of Ghana, including leading the Quality & Patient Safety program in its largest teaching hospital.

I would like to use this Fellowship as a learning platform and an opportunity to acquire the requisite knowledge, skills and competencies to complement ongoing efforts by like-minded individuals and organizations to continuously advance improve the quality and patient safety in Ghana and the continent.

This will close in 0 seconds

Stephen Taiye Balogun


Stephen is a Senior Programme Officer at the Institute of Human Virology in Nigeria as well as Country Representative for Health Information for All (HIFA).

Stephen plans to use this opportunity to maximise his impact by championing the cause of patient safety and quality in Nigeria and across Africa.

Stephen says "Quality and safety is a major wheel through which universal healthcare coverage can be achieved. The goal is to be a bridge in the gap between the International Quality Improvement and Patient Safety community and my country to ensure rapid spread, adoption, implementation and practice."

We are looking forward to working with both Stephen and our 2020 winner Rhoda Kalondu over the next year.

This will close in 0 seconds

Dr Rhoda Kalondu


Rhoda is the Head of the Patient Safety Unit at Kenyatta Hospital in Nairobi and wants to use this Fellowship to learn how to establish a culture of safety and develop systems for assessment and analysis at her institution, and more widely. As well as this, Rhoda intends to develop and execute an intervention to improve patient safety in Kenyatta National Hospital.

It is one thing to institute measures and processes for improvement, but quite another to change the culture of an environment. Rhoda's ambition to lead others in this change inspired the panel.

This will close in 0 seconds

Dr Subhrojyoti Bhowmick


I am an MBBS graduate from Calcutta University with a Gold Medal in Gynecology & Obstetrics.

I have completed M.D in Pharmacology from IPGME& R, Kolkata and have over 12 years of experience in the field of Clinical Research, Pharmacovigilance and Medication management in Hospitals.

I have completed certification in Clinical Research Administration & Project Management from Stanford University, USA and in Patient Safety from Johns Hopkins University, USA.

I am an Assessor for National Accreditation Board for Hospitals & Health care providers (NABH), India assessing hospitals for medication safety and clinical quality standards and NABH Assessor for Ethics Committee Accreditation program in India as well.

I serve as the Chairperson, Institutional Ethics Committee of Health Point Hospital, Kolkata and am associated with 2 other Hospital ethics committees as a member.

I finished my Fellowship in Healthcare Quality from the International Society of Quality in Healthcare (ISQua) from Ireland in 2017.

I have published several research articles and have also authored a chapter on “Regulations governing Clinical Trial” in the book “Fundamentals of Clinical Trial & Research”.

I am a peer reviewer for prestigious international journals like the British Journal of Clinical Pharmacology, CNS Drugs and Drug Safety case reports.

I am the recipient of the UK Seth Oration Award for Best Clinical Pharmacology paper by the Indian Pharmacological Society in 2009 and the “Most promising Healthcare professional in Patient Safety in India” award by the Asian African Chamber of Commerce and Industry in October 2018.

Recently in April 2019, I received the Young Quality Achiever award by Consortium of Accredited Healthcare Organizations (CAHO), India for 2019 for my work in the field of medication safety and clinical research.

I have a keen interest in teaching and am visiting adjunct faculty of Pharmacology at KMC, Mangalore, India and for Healthcare technology at MAKAUT, Kolkata, India.

I was associated with Stanford University School of Medicine, in the USA as a Senior Clinical Research Associate from 2015 to 2017 and have certification in Biostatistics, Evidence-based Medicine and Medical Writing from Stanford University.

Currently, I am working as the Clinical Director of Academics, Medical Quality and Clinical Research at Peerless Hospital and B K Roy Research Centre, Kolkata.

I am very happy and thrilled to receive the prestigious ISQua Lucian Leape Patient safety Fellowship Award for 2019 and I look forward to honing my skills further in the field of healthcare quality and patient safety through my experiences during this fellowship.

I sincerely believe that successful completion of this fellowship will help me evolve as a more confident Patient safety leader in India who in turn can provide significant inputs on policy changes through NABH for the Indian healthcare system.

This will close in 0 seconds